Strategies for capillary electrophoresis: Method development and validation for pharmaceutical and biological applications-Updated and completely revised edition
- PMID: 37537327
- DOI: 10.1002/elps.202300158
Strategies for capillary electrophoresis: Method development and validation for pharmaceutical and biological applications-Updated and completely revised edition
Abstract
This review is in support of the development of selective, precise, fast, and validated capillary electrophoresis (CE) methods. It follows up a similar article from 1998, Wätzig H, Degenhardt M, Kunkel A. "Strategies for capillary electrophoresis: method development and validation for pharmaceutical and biological applications," pointing out which fundamentals are still valid and at the same time showing the enormous achievements in the last 25 years. The structures of both reviews are widely similar, in order to facilitate their simultaneous use. Focusing on pharmaceutical and biological applications, the successful use of CE is now demonstrated by more than 600 carefully selected references. Many of those are recent reviews; therefore, a significant overview about the field is provided. There are extra sections about sample pretreatment related to CE and microchip CE, and a completely revised section about method development for protein analytes and biomolecules in general. The general strategies for method development are summed up with regard to selectivity, efficiency, precision, analysis time, limit of detection, sample pretreatment requirements, and validation.
Keywords: biopharmaceuticals; capillary electrophoresis; method development; troubleshooting; validation.
© 2023 The Authors. Electrophoresis published by Wiley-VCH GmbH.
References
REFERENCES
-
- Wätzig H, Degenhardt M, Kunkel A. Strategies for capillary electrophoresis: method development and validation for pharmaceutical and biological applications. Electrophoresis. 1998;19:2695-752.
-
- Shapiro M. An FDA perspective on the implementation of state-of-the-art analytical methods for therapeutic proteins. 2018. Available from: https://www.casss.org/detail-pages/resource/an-fda-perspective-on-the-im...
-
- Peng L, Gao X, Wang L, Zhu A, Cai X, Li P, et al. Design of experiment techniques for the optimization of chromatographic analysis conditions: a review. Electrophoresis. 2022;43:1882-98.
-
- Vessman J, Stefan RI, van Staden JF, Danzer K, Lindner W, Burns DT, et al. Selectivity in analytical chemistry (IUPAC Recommendations 2001). Pure Appl Chem. 2001;73:1381-6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
